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Connecting phosphorylation events to kinases and
phosphatases is key to understanding the molecular
organization and signaling dynamics of networks.
We have generated a validated set of transgenic
RNA-interference reagents for knockdown and char-
acterization of all protein kinases and phosphatases
present during early Drosophila melanogaster devel-
opment. These genetic tools enable collection of suf-
ficient quantities of embryos depleted of single gene
products for proteomics. As a demonstration of an
application of the collection, we have used multi-
plexed isobaric labeling for quantitative proteomics
to derive global phosphorylation signatures associ-
ated with kinase-depleted embryos to systematically
link phosphosites with relevant kinases. We demon-
strate how this strategy uncovers kinase consensus
motifs and prioritizes phosphoproteins for kinase
target validation. We validate this approach by
providing auxiliary evidence for Wee kinase-directed
regulation of the chromatin regulator Stonewall.
Further, we show how correlative phosphorylation
at the site level can indicate function, as exemplified
by Sterile20-like kinase-dependent regulation of
Stat92E.
INTRODUCTION
Despite the ease with which we can identify protein phosphory-
lation, in the vast majority of cases, the protein kinase(s) or
phosphatase(s) responsible for controlling any particular phos-
phorylation event is unknown.We sought to develop a proteomic
strategy to easily and systematically screen for candidate protein
kinase and phosphatase substrates in Drosophila melanogaster
embryos, with the goal of identifying specific residues that these
enzymes target in the context of development. D. melanogaster
is an ideal model for the dissection of signaling mechanisms, as
the majority of transcription in the embryo occurs after the mid-
blastula transition (MBT), and thus, transcriptional feedback has114 Developmental Cell 31, 114–127, October 13, 2014 ª2014 Elsevrelatively no impact on the phosphoproteome in early embryos.
Additionally, since the embryo is a syncytium prior to cellulariza-
tion at theMBT, distortions in phosphosite measurements due to
contributions from multiple cell types can be avoided. However,
acquiring sufficient material from mutant embryos for proteomic
studies is a challenge. The classical technique to generate
maternally deficient embryos—relying on the production of
germline clones using the flippase (FLP) recombinase-mediated
dominant female sterile technique (Chou and Perrimon, 1996)—
is labor intensive, as it involves the construction of complex
genotypes. Moreover, background mutations on the FLP-recog-
nition-target-bearing chromosome can confound phenotype
interpretation, and the approach does not typically yield enough
material for proteomic studies.
Here, we describe how we have used genetic manipulation by
transgenic RNA interference (RNAi) to derive sufficient quantities
of embryos for phosphoproteomic analyses. RNAi is a well-
founded method to analyze gene function in D. melanogaster
(Perrimon et al., 2010), but the efficacy of RNAi during early
embryogenesis has only recently been improved to enable
robust gene knockdown during this developmental stage (Ni
et al., 2011). By using the Gal4/UAS system (Brand and Perri-
mon, 1993) to temporally and spatially restrict expression of
RNAi reagents, we confined protein kinase and phosphatase
knockdown specifically to the germline. Using this strategy, we
were able to query maternal gene function without affecting
the viability of the animal, since an intact germline is dispensable
for organismal development. We generated and validated a
transgenic RNAi library that targets all protein kinases and phos-
phatases expressed in the D. melanogaster germline. Through
rigorous characterization of our collection, we uncovered
maternal-effect genes and verified previously implicated kinases
and phosphatases in early D. melanogaster development.
Furthermore, we systematically monitored global phosphopro-
teome alterations in kinase-deficient embryos for the purpose
of illustrating how the method can generate lists of candidate ki-
nase substrates. The approach illuminated kinase-dependent
signaling and permitted the unbiased prediction of kinase
consensus motifs that match kinase specificities previously
characterized in vitro. As anticipated, the strategy identified
downregulated phosphoproteins that include bona fide kinase
substrates of the depleted kinase and an extensive list of candi-
date kinase-targeted substrates and phosphosites. We furtherier Inc.
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Figure 1. Expression and Conservation of
Protein Kinases and Protein Phosphatases
during Early D. melanogaster Embryogen-
esis
(A) Of 269 D. melanogaster protein kinase-encod-
ing genes, 201 were identified by RNA-seq be-
tween 0 and 4 hr of embryogenesis, while 76 of 112
protein phosphatase-encoding transcripts were
identified for the same developmental window.
Represented is an average RPKM value from two
time points comprising stages 1–8. Undetected
transcripts are those with an RPKM value less than
3. Average RPKM values ranged from high (257:
polo) to low (3: btl, PVR, and CG43143) for kinases
and from high (327: mts) to low (3: CG565 and
CG16771) for phosphatases. Corresponding pro-
teins, identified from MS2-based peptide frag-
mentation, were quantified based on label-free
peptideMS1 feature intensities from shotgunmass
spectrometry for the same developmental time. A
total of 172 kinases and 67 phosphatases were
quantified. Median signal-to-noise ratios observed
across all matching peptides ranged from high
(156: Cks30A) to low (5: CG7156) for kinases and
from high (107: Pp2B-14D) to low (6: CG8147 and
Ptp4E) for phosphatases.
(B) Conservation of expressed (outer ring) and
undetected (inner pie) D. melanogaster protein
kinases during early embryogenesis (0–4 hr) to
human and yeast.
(C) Conservation of expressed (outer ring) and undetected (inner pie) D. melanogaster protein phosphatases during early embryogenesis (0-4 hr) to human and
yeast. Conservation was considered when three or more ortholog predictions tools (DIOPT score > 3) predicted a high confidence ortholog.
See also Figure S1.
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same direction (positive correlation) or the opposite direction
(negative correlation) in different genetic contexts can illuminate
phosphosite functionality. Given the extensive similarity between
human and D. melanogaster kinases, and the conservation of
functional phosphorylation (Gnad et al., 2010; Landry et al.,
2009), we anticipate that insight gained from our data and ana-
lyses will inform future mammalian studies.
RESULTS
Compilation of the Maternally Inherited Protein Kinome
and Phosphatasome
The D. melanogaster genome encodes 32 tyrosine kinases, 237
serine/threonine kinases, and 112 protein phosphatases (Mann-
ing et al., 2002; Morrison et al., 2000). To systematically link pro-
tein phosphorylation sites with their cognate kinases and phos-
phatases in D. melanogaster, we first identified the
complement of kinase and phosphatase messenger RNAs
(mRNAs) that are deposited maternally and contribute to the
early zygote by analyzing developmental time course RNA
sequencing (RNA-seq) data (Graveley et al., 2011). Using an
RPKM (reads per kilobase of exon model per million mapped
reads) cutoff of 3, determined by comparison to real-time quan-
titative PCR (qPCR) analysis of staged embryos (Hu et al.,
2013b), we determined that 201 protein-kinase-encoding tran-
scripts and 76 protein phosphatase-encoding transcripts (Fig-
ure 1A; Table S1 available online) are present during the first
4 hr of embryogenesis (stages 1–8). This accounts for 75%Developmand 68% of all protein kinases and phosphatases, respectively,
encoded in the D. melanogaster genome (Figure 1A). We inde-
pendently verified the presence of these transcripts by real-
time qPCR (Figure 2A) but detected only 172 kinases and 67
phosphatases in 2-hr-old embryos (stages 1–4) at the protein
level based on peptide MS1 feature intensities from shotgun
mass spectrometry (Figure 1A). Most kinases and phosphatases
we identified as transcripts were reliably detected as protein. We
found that, for only 28 kinases and 9 phosphatases wheremRNA
was identified, the corresponding protein at the appropriate time
interval was not detected (Table S1). Thus, mRNA detection was
generally a good predictor of protein presence. However, when
considering levels rather than identity, we found no correlation
between mRNA and protein (Figure S1), similar to observations
from large-scale studies in Schizosaccharomyces pombe (Mar-
guerat et al., 2012). Using a stringent criterion of conservation
(i.e., at least three independent prediction tools support an or-
thologous gene-pair relationship; Hu et al., 2013a), we found
that nearly all protein kinases and phosphatases expressed dur-
ing early D. melanogaster development are conserved to human
(Figures 1B and 1C; Table S1). On the contrary, conservation to
yeast is far more limited.
Generation and Validation of the Transgenic shRNA
Collection Targeting Kinases and Phosphatases
We previously demonstrated the utility of short hairpin RNAs
(shRNAs) embedded in an endogenous microRNA scaffold to
knock downmaternal gene function inD.melanogaster embryos.
A side-by-side comparison of shRNA with long double-strandedental Cell 31, 114–127, October 13, 2014 ª2014 Elsevier Inc. 115
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Figure 2. Knockdown Efficiency of Mater-
nally Expressed shRNAs
(A) Plotted is the average remaining transcript level
for individual protein kinases and phosphatases
targeted by a specific shRNA, relative to a shRNA-
targeting EGFP, as assessed by real-time qPCR.
Three reference genes were used for normaliza-
tion. Approximately 12% of the lines could not be
analyzed, since germline knockdown of these
genes induced female sterility (no eggs). Indicated
in red are lines that generated phenotypes.
(B) Lysate from 0–4 hr embryos was subjected to
immunoblotting, and levels of the corresponding
kinase or phosphatase were assessed relative to
tubulin. Indicated below the immunoblots is the
extent of knockdown determined by RT-qPCR,
achieved for the corresponding shRNA.
See also Figure S2.
Developmental Cell
Surveying Phosphorylation Networks in DrosophilaRNA (dsRNA) transgenic lines indicates that screening of shRNA
lines triples the frequency of RNAi-derived germline phenotypes
(Yan et al., 2014), generally due to higher expression of shRNAs in
the germline (Ni et al., 2011). Having characterized the require-
ments for efficient gene knockdownduring oogenesis,we sought
to generate a complete and validated set of shRNA-expressing
transgenic lines capable of targeting protein kinases and phos-
phatases that are contributed maternally to the developing
embryo. To induce shRNA expression specifically in the female
germline using the Gal4-UAS system, we crossed females het-
erozygous for a UAS shRNA and either MTD-Gal4 (a line bearing
three copies of Gal4 expressed sequentially throughout oogen-
esis; Petrella et al., 2007) or tub-Gal4 (a linebearing two insertions
of Gal4 expressed from a maternal tubulin promoter during mid-
and late oogenesis; Staller et al., 2013) to shRNA-bearing males
in order to recover fertilized eggs. We analyzed more than 450
transgenic lines expressing shRNAs targeting protein kinases
and phosphatases (Table S2). We were unable to recover eggs
from 12% of the lines crossed to MTD-Gal4, accounting for
46 kinases and 6 phosphatases and implying that these genes
are required for early oogenesis.
For those lines from which we could recover eggs, we deter-
mined by real-time qPCR, following the Minimum Information
for Publication of Quantitative Real-Time PCR Experiments
guidelines (Bustin et al., 2009), that more than half of the 450116 Developmental Cell 31, 114–127, October 13, 2014 ª2014 Elsevier Inc.transgenic lines we analyzed generated
greater than 60% knockdown of corre-
sponding kinase or phosphatase mRNA
levels in 0-4 hr embryos, relative to a con-
trol shRNA targeting enhanced green
fluorescent protein (EGFP) (Figures 2A
and S2A). We observed excellent correla-
tion between knockdown at the mRNA
and protein level, which was assessed
by comparing mRNA levels assessed by
real-time qPCR to immunoblots of a sub-
set of proteins for which antibodies were
available (Figure 2B). We were interested
in determining the number of transgenic
lines that would need to be consideredto observe at least one achieving >60% knockdown of the tar-
geted transcript. We found that, when considering two unique
shRNAs targeting the same gene product, this occurs at a fre-
quency of 86% (N = 81 pairs) (Figure S2B). These data suggest
that generating two independent shRNA lines is usually sufficient
for obtaining at least one line that confers adequate knockdown.
Interestingly, many cases of poor knockdown can be attributed
to shRNA targeting design. Specifically, our data indicate that
shRNAs targeting the transcript coding sequence (CDS) are
more effective at knockdown than those targeting 30 untrans-
lated regions (UTRs) (Figure S2C), possibly reflecting inaccura-
cies in UTR annotation (Hu et al., 2013b).
Notably, we found no correlation between the degree of
knockdown and the level of corresponding transcript in un-
treated early embryos (Figure S2D). Furthermore, our data
exhibit no bias toward the concentration of recovered RNA or
the date of sample collection (Figures S2E and S2F). Taken
together, our collection consists of at least one transgenic line
that provides a minimum of 60% knockdown for eachmaternally
inherited protein kinase and phosphatase.
Assessment of Transgenic shRNA Collection
Phenotypes
Our shRNA-directed knockdown strategy recapitulated many
documented maternal-effect phenotypes (Figure 3A). As
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Figure 3. Embryonic PhenotypesGenerated from shRNA-MediatedKnockdownofMaternally Contributed Protein Kinase andPhosphatases
(A) Cuticle phenotypes of embryos derived from maternal-Gal4>UAS-shRNA females crossed to UAS-shRNA males. Description of associated phenotypes can
be found in Table S2.
(B) Frequency of observed embryonic phenotypes derived from maternal-Gal4/UAS-shRNA females crossed to UAS-shRNA males, from of a total of 450
examined lines.
(C) Twenty-four pairs of shRNAs targeting the same gene and generating >60% knockdown were compared for qualitatively similar embryonic phenotypes. Four
of the six cases of a differential phenotype can be explained by degree of knockdown.
See also Table S2.
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Figure 4. Phosphoprofiles of Kinase-DeficientD.melanogaster Embryos Generated by Quantitative Mass Spectrometry and Isobaric Label-
ing with Tandem Mass Tags
(A) Strategy followed to identify differential phosphorylation between kinase shRNA and control shRNA embryos (see Supplemental Experimental Procedures for
details).
(B) Relative phosphosite levels between kinase shRNA and control shRNA embryos. Plotted is the fold change relative to a control shRNA (white) for phosphosites
found among all experiments. These 1,139 unique phosphopeptides meet stringent criteria in terms of isolation specificity and phosphosite assignment (see
Experimental Procedures). The hierarchical 2D matrix is clustered based on a correlation distance metric using average linkage. Knockdown efficiencies are as
follows:Cdk8, 87%;Cks30A, 85%; slik, 92%;wee, 81%; Tao, 91%;mei-41, 84%; tefu, 68%; lkb1, 86%; Atg1, 92%; Bub1, 99%; grp, 79%; cg3608, 89%;Gprk2,
82%; cdc2rk, 85%; gish, 58%; mos, 90%; Csk, 90%; Pak, 95%; Eip63E, 71%.
(legend continued on next page)
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following the disruption of terminal signaling, such as that result-
ing from knockdown of the receptor tyrosine kinase torso, the
SHP2 phosphatase ortholog corkscrew, or the downstream ki-
nase suppressor of ras, ksr (Figure 3A). Altogether, we observed
maternal-effect phenotypes for 18% of lines that achieved
60% or greater knockdown (Figure 3B; Table S2), representing
approximately 33% and 18%, respectively, of protein kinases
and phosphatases expressed during early embryogenesis. Of
those protein kinases and phosphatases for which a maternal-
effect phenotype has been reported, we observed the same
qualitative phenotype as that described in the literature approx-
imately 74% of the time (26/35 genes considering germline
clone-derived embryos; 2/3 considering embryos derived from
homozygous mutant mothers; Table S3A). Anomalies can likely
be attributed to: (1) weak hypomorphic alleles generating a
less severe phenotype than extensive knockdown; (2) insuffi-
cient knockdown by an shRNA to produce phenotypes gener-
ated by strong or null mutant alleles; or, (3) in the case of embryos
derived frommutant mothers, an effect resulting frommutant so-
matic follicular cells. Despite the fact that protein kinases and
phosphatases are among the best characterized classes of
genes, we uncovered unappreciated phenotypes for approxi-
mately 40 of these enzymes, implying roles in oogenesis and
early embryogenesis. Further, knockdown of an additional 12
predicted kinases and phosphatases resulted in oogenesis and
maternal-effect phenotypes, warranting more extensive charac-
terization. A searchable interface to query genes for individual
transgenic lines, a description of their knockdown and embry-
onic phenotypes, and photos of cuticle preparations for those
with maternal-effect phenotypes can be found at http://www.
flyrnai.org/RSVP.html.
We addressed the possibility and frequency of shRNAs gener-
ating phenotypes as a result of off-target effects (OTEs) in two
ways. First, we compared pairs of unique shRNAs targeting the
same gene for similar phenotypes. Comparing 24 efficient tar-
geting pairs, we found that 80% produced the same qualitative
phenotype (Figure 3C; Table S3B). Four of the six cases of a dif-
ferential phenotype can be explained by the extent of knock-
down. Second, we established transgenic lines expressing
‘‘C911’’ versions of a targeting shRNA: a near-identical shRNA
but with complementary nucleotides situated at positions
9–11. Themismatched shRNA precludes on-target binding while
maintaining off-target binding since antisense and sense seed
sequences remain intact (Buehler et al., 2012). Consistent with
phenotypes resulting from on-targeting specificity provided by
perfect complementary of the shRNA, we eliminated phenotypes
resulting from expression of 16 unique shRNAs by mutating the
central three nucleotides of the shRNA. We verified by real-time
qPCR that mutation of these three residues eliminated knock-
down of corresponding kinase transcripts that the shRNA origi-
nally targeted (data not shown). Thus, we conclude that the prev-
alence of OTEs affecting early embryogenesis is minimal with the
shRNA targeting strategy.(C) Phosphoproteins with two ormore downregulated phosphosites (>1.5-fold) we
of identified phosphosites for the same protein: type 1,most identified phosphosite
3, all identified phosphosites are downregulated; and type 4, most identified pho
See also Figures S3 and S4.
DevelopmA Resource Providing Accessibility for Proteomic
Analyses and Kinase Characterization
Our current reagents for germline-specific RNAimake it relatively
easy to obtain large numbers of eggs depleted of a single gene
product. This allowed us to perform quantitative proteomic ex-
periments to measure the global effect of each perturbation on
the phosphoproteome (Figure 4A). We anticipated that a relative
quantitative and global assessment of altered phosphorylation in
protein kinase-deficient embryonic extracts could provide a list
of putative protein kinase-substrate (KS) and phosphosite
matches. We also reasoned that phosphorylation signatures
could also be used to predict roles for protein kinases and phos-
phatases in specific biological processes and reveal functional
redundancy.
We initially assessed the reproducibility of phosphoproteomic
profiles generated from analysis of separate populations of con-
trol shRNA embryos. We utilized mass spectrometry and an
isobaric labeling strategy (see the Protocol) that enables multi-
plexing and relative quantification between samples (see Sup-
plemental Experimental Procedures). Since 700 embryos
constitute the amount of material (1 mg protein) we chemically
label, the phosphoproteomic profile is a representative average
of phosphorylation in this population. Amine-reactive TMT
Isobaric Mass Tags, identical in mass but differing in their iso-
topic distribution of atoms, permit the simultaneous spectral
identification of unique reporter ions generated fromMS2-based
fragmentation of each tag from labeled peptides. We compared
TMT reporter ion intensities and phosphopeptide identities from
three TMT-labeled control shRNA embryo populations in two in-
dependent experiments (Table S4). When considering those
phosphopeptides in the same multiplex experiment (10,166
phosphopeptides for one experiment and 8,032 for the other;
see Supplemental Experimental Procedures for normalization
and specific criteria), we generally identify the same phospho-
peptide in all three biological replicates (99% of the time). In
the two independent experiments, we observed phosphopep-
tide levels deviating an average of 7% (Figure S3A) and 29%
(Figure S3B) between three biological replicates. This indicates
that variability in factors such as peptide labeling and embryo
collection has little influence on our ability to consistently detect
the majority of phosphopeptides.
Given the reproducibility between control shRNA replicates,
we extended our phosphoproteomic examination to embryos
derived from females expressing efficient shRNAs (as deter-
mined by real-time qPCR) targeting 19 different protein kinases
(Figure 4B). We were able to quantify nearly 8,500 unique phos-
phosites among 19 deficient kinase samples (Tables S5A–S5D).
The number of unique phosphosites we quantified between ex-
periments, ranging from 6,331 to 2,448, was based on the num-
ber of unique phosphopeptides identified per experiment,
ranging between 22,942 and 12,201. Notably, 1,140 phospho-
sites were quantified in all 19 kinase knockdown conditions,
1,343 in ten kinase knockdown conditions, and 4,358 in five ki-
nase knockdown conditions. The majority of phosphopeptidesre classified into four types based on the directionality of change of themajority
s do not change; type 2,most identified phosphosites are downregulated; type
sphosites are upregulated.
ental Cell 31, 114–127, October 13, 2014 ª2014 Elsevier Inc. 119
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relative to the same control shRNA included in each multiplex
experiment. In terms of candidate kinase-targeted phospho-
sites, either direct or indirect, we consider those downregulated
sites with changes of 1.5-fold or greater in kinase-deficient em-
bryos relative to control embryos, since observed phosphopep-
tides for seven shRNA-targeted kinases—Wee, Tao, Atg1,
Gilgamesh (Gish), Lkb1, Grapes (Grp), and Sterile20-like
kinase (Slik)—minimally met this criterion (2.27-fold, 1.95-fold,
1.69-fold, 2.24-fold, 2.68-fold, 1.98-fold, and 2.1-fold, respec-
tively) in corresponding kinase-deficient embryos (Figure S4A).
We did not detect phosphopeptides for the other 12 shRNA-tar-
geted kinases. Moreover, changes in the phosphorylation of
known substrates of shRNA-targeted kinases approach this
value; for instance, Histone H3, Med13, and Stat92E (downregu-
lated 2.2-fold, 1.8-fold, and 2.4-fold, respectively) in Cdk8-defi-
cient embryos and Cdk1, Klp61F, and Hsp83 (downregulated
1.4-fold, 2.1-fold, and 1.7-fold, respectively) in wee-deficient
embryos. Indeed, for a third of the D. melanogaster orthologs
of literature-curated Cdk8 substrates in yeast (Sharifpoor et al.,
2011) we identified, one or more respective phosphopeptides
were downregulated >1.5-fold in Cdk8-deficient embryos (Table
S5E). Using this criterion, the number of downregulated phos-
phosites in kinase-deficient profiles ranged from 22 (Bub1-defi-
cient embryos) to 752 (Cdk8-deficient embryos) (Table S5). Of
note, while ourBub1-targeting shRNA generated efficient knock-
down (99% knockdown), Bub1-deficient embryos exhibited no
morphological or hatch rate defects (Table S2), consistent with
minimal effects on the phosphoproteome. Conversely, knock-
down of Cdk8, a cyclin-dependent kinase influencing transcrip-
tion and cell cycle progression (Szilagyi and Gustafsson, 2013),
resulted in dramatic and penetrant morphological and hatch
rate phenotypes, consistent with extensive modulation of the
observed phosphoproteome. We speculate that among those
phosphosites downregulated >1.5-fold in the 19 kinase-deficient
contexts we surveyed are sites directly targeted by the corre-
sponding depleted kinase(s), as well as indirect targets altered
downstream of the manipulated kinase. For instance, in the
case of gish-deficient embryos, we observed enrichment of
downregulated phosphorylation of proteins involved in Hedge-
hog (Hh) and Wnt/Wingless (Wg) pathways (Table S5B), consis-
tent with a role for Gish in mediating Hh and Wg signaling
(Davidson et al., 2005; Hummel et al., 2002). These data indicate
that, by monitoring changes in the phosphoproteome, one can
effectively screen for candidate substrates and alterations in
signaling downstream of the targeted kinase. However, further
scrutiny of any altered phosphosite is required to prove a KS rela-
tionship, as we demonstrate later.
In order to distinguish genuine kinase targets from phospho-
site alterations due to protein instability, we classified phospho-
proteins with two or more downregulated phosphosites
(>1.5-fold) into five categories based on the directionality of
change of the majority of identified phosphosites for each indi-
vidual protein: type 1, the majority of phosphosites do not
change; type 2, themajority of phosphosites are downregulated;
type 3, all phosphosites are downregulated; type 4, most phos-
phosites are upregulated; and type 5, indistinguishable due to an
equal distribution of unchanged, upregulated, or downregulated
phosphosites (Figure 4C). In considering at least two phospho-120 Developmental Cell 31, 114–127, October 13, 2014 ª2014 Elsevsites, we increase the probability that the corresponding phos-
phoprotein is indeed subjected to degradation and not merely
reduced in phosphorylation at a single site. Type 1 and type 4
phosphoproteins are those for which we can reasonably dis-
count the possibility of protein degradation as a mechanism of
downregulated phosphorylation and, thus, are considered
high-priority candidates for phosphorylation by the respective
kinase. The observed downregulation of type 3 phosphopro-
teins, on the other hand, can be explained by indirect mecha-
nisms leading to protein degradation, such as altered protein-
protein interactions or phosphorylation-mediated degradation.
Althoughmost phosphoproteins in our data set are of type 1 (Fig-
ure 4C), type 3 phosphoproteins account for20%, on average,
of those proteins with two or more downregulated phosphosites
in each kinase depletion condition. This percentage is in line with
previous reports that protein expression changes account for
less than 25% of differential phosphorylation (Bodenmiller
et al., 2010; Wu et al., 2011). We scrutinized respective tran-
scripts for type 2 and type 3 phosphoproteins in order to identify
and filter our data set of potential OTEs due to partial comple-
mentarity of the targeting shRNA to unintended transcripts. By
comparison to the frequency of partial complementarity of
each targeting shRNA (seven-nucleotide match to seed) to the
early embryonic transcriptome, we find a relatively weak proba-
bility for partial complementarity of our targeting shRNAs to 30
UTRs or transcripts of type 2 phosphoproteins (see Supple-
mental Information). This probability declines when considering
type 3 phosphoproteins, indicating that off-targets are not en-
riched in our data set and are therefore unlikely to explain alter-
ations observed in our analyses. To further substantiate this
assumption, we proceeded to knock down respective tran-
scripts for type 3 phosphoproteins with the best matches to
each corresponding kinase shRNA seed. Germline-specific
knockdown of ten candidate off-targets predicted for six ki-
nase-targeting shRNAs failed to generate phenotypes that could
explain specific phenotypes attributed to the corresponding
kinase shRNA (see Supplemental Information).
Extracting Patterns in Phosphorylation Data Sets to Find
KS Relationships
We speculated that we might be able to extract KS relationships
and insight into signaling pathway connectivity from our phos-
phorylation data set as a whole by examining patterns in phos-
phoalterations among kinase-deficient contexts. For instance,
since most kinases are activated by phosphorylation, correlative
phosphorylation events observed between kinases and other
proteins could be indicative of KS relationships. On the other
hand, anticorrelative phosphorylation could be additionally infor-
mative; inhibitory phosphorylation of a kinase would always be
out of phase with phosphorylation of that kinase’s respective tar-
gets. To explore such possibilities, we surveyed correlations in
phosphorylation changes (>1.5-fold cutoff relative to a control
shRNA) between identified phosphosite pairs among our
kinase-deficient conditions (447,585 correlative pairs involving
2,058 phosphosites; Table S6A). When considering phosphosite
pairs exhibiting positive or negative correlation in at least four
kinase-deficient conditions (25,077 correlative pairs), we find
enrichment for authentic KS pairs (Figure 5A), derived from
133,051 D. melanogaster KS pairs (Table S6B) predicted fromier Inc.
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Figure 5. Correlative Phosphorylation Anal-
ysis Enriches for KS Pairs and Can Reveal
Signaling Mechanisms
(A) Positive and negative correlations in phos-
phorylation changes (>1.5-fold relative to a control
shRNA) between any two phosphosites (PS) were
extracted from kinase-deficient phosphorylation
profiles. Yeast gold standard (YGS) KS pairs
(Sharifpoor et al., 2011) were mapped to
D. melanogaster using DIOPT (Hu et al., 2011).
D. melanogaster KS pairs were also predicted
based on human kinase phosphorylation motifs
from the NetPhorest atlas (Miller et al., 2008). The
distribution of expected overlap between KS pairs
and 1,000 simulated random correlation pairs of
the same size is shown, and the overlap is shown in
gray. The number of KS pairs observed among all
correlation pairs is indicated (red arrow). Illustrated
is the number of pairs when requiring phosphosite
correlations among at least four kinase-deficient
phosphorylation profiles. Z scores and p values are
indicated.
(B) For those kinase-deficient embryonic lysates
where phosphopeptides encompassing SlikS1376
and StatY711 were detected, we observed a posi-
tive correlation in the direction of alteration for
these two phosphosites, relative to control.
(C) Comparison of common phosphoproteins in
slik-deficient embryos (exhibiting >1.3-fold down-
regulation compared to control embryos) to
Drosophila cells following 10–30 min insulin stim-
ulation.
(D) The expression of Stat target genes upd and
socs36E in Drosophila cells subjected to slik
knockdown and stimulated with Upd ligand. Error
bars indicate SEM.
(E) Activated Akt1 (phosphorylation at Ser505)
levels in 0–4 hr slik-deficient embryos. Total Akt1
and tubulin serve as loading controls.
See also Figure S5.
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NetPhorest (Miller et al., 2008) and from mapping of 517 gold
standard KS pairs in yeast (Sharifpoor et al., 2011) to
D. melanogaster. Enrichment for authentic KS pairs still exists
when considering phosphosite pairs correlating in only two or
three kinase-deficient conditions (Figure S5A). Strikingly, we
also find enrichment for correlative phosphorylation among
components of the same protein complex (p = 7.5 3 10157),
further substantiating how this phenomenon can be exploited
to identify functionally relevant phosphosites.
While correlative analysis can clearly illuminate direct KS rela-
tionships in large-scale phosphorylation data, it can also provide
functional information if one has a priori knowledge of the conse-
quence of phosphorylation of one of the participating phospho-
sites. We exemplify this with the case of Slik and Stat92E.
Phosphorylation of the Stat92E transcription factor at Tyr711
promotes DNA binding (Yan et al., 1996). We found that phos-
phorylation at this particular site positively correlates with phos-
phorylation of Slik at Ser1376 (Figure 5B), suggestive of a rela-
tionship between Slik and Stat92E; the probability of observing
two phosphosites correlating among six kinase-deficient profiles
is rare (p = 1.43 105). We predicted that Slik activates Stat92E
given that reduced Stat92E phosphorylation in slik-deficient em-Developmbryos (Figure 5C) cannot be explained by instability of Stat92E
protein (Figure S5B). Indeed, Stat92E target gene expression
was downregulated in slik dsRNA-treated cells (Figure 5D). Insu-
lin has been reported to enhance growth hormone-induced Stat
activation in mature adipose cells (Zhang et al., 2013), and Stat
may be a direct target of the insulin receptor (Sawka-Verhelle
et al., 1997). We confirmed an increase in the activating phos-
phorylation of Stat92E in cells treated with insulin (Figure 5C).
Remarkably, we observed that more than a quarter of phospho-
proteins downregulated in slik-deficient embryos are upregu-
lated in cells in response to insulin, including Slik (Figure 5C; Fig-
ures S5E and S5F). Moreover, 30% of phosphoproteins
downregulated >1.3-fold in slik-deficient embryos (Table S7)
were found to physically interact with components of the insu-
lin-signaling network (Glatter et al., 2011). These observations
suggest that Slik could be activating Stat92E via insulin
signaling. Consistent with this, we observed a reduction in acti-
vated Akt1 in slik-deficient embryos, despite elevated total Akt1
protein (Figure 5E). A reduction in insulin signaling may, in fact,
explain the longevity of slik1 mutant larvae (Hipfner and Cohen,
2003). Raf interaction has been suggested to bridge Slik to the
MAPK proliferation branch of cell survival signaling (Hipfner




Figure 6. Phosphoproteomic Characterization of wee-Deficient Embryos
(A) Indicated are motifs encompassing phosphosites that are enriched among phosphosites altered >1.5-fold in wee-deficient embryonic lysates relative to
control. Motif-X was used to identify motifs (Chou and Schwartz, 2011). The PLogo tool was used to generate motif logos. Favored amino acids at corresponding
positions are indicated above the black line, while disfavored amino acids are below. ‘‘0’’ indicates the site of phosphorylation.
(B) Levels of a Cdk1 Tyr15 encompassing phosphopeptide in wee-deficient embryos relative to control embryos (w, white) as determined by TMT reporter ion
signal (right) from the corresponding peptide identified by MS2 fragmentation (left, MS2 spectra). The hashtag indicates the localized site of phosphorylation (p <
0.05). Indicated is a representative peptide.
(C) Of 308 phosphoproteins identified as Cdk1 substrates in yeast (Holt et al., 2009), we mapped 120 to fly with a DIOPT score R 1. Half of the orthologous
D. melanogaster counterparts exhibit altered phosphorylation (>1.3-fold) in wee-deficient embryos.
(D) Approximately half of those phosphosites upregulated >1.3-fold in wee-deficient kinases can be attributed to Cdk and the downstream kinase Aurora based
on kinase consensus motif matching.
(E) Gene Ontology Consortium term enrichment among altered phosphoproteins (>1.5-fold) in wee shRNA embryos relative to control embryos, identified using
the DAVID Functional Annotation Tool.
(F) Levels of a Stwl Tyr305 encompassing phosphopeptide in wee-deficient embryos relative to control embryos (w, white) as determined by TMT reporter ion
signal (right) from the corresponding peptides identified by MS2 fragmentation (left, MS2 spectra). The hashtag indicates the site of phosphorylation (p < 0.05).
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ure S5D). Despite a nonessential role for slik in embryogenesis,
our examination of correlative phosphorylation during this early
stage illuminated Slik function, highlighting the power of our
approach.
An Examination of Wee-Dependent Phosphorylation
Wechose to examinemore closely the phosphoproteomic profile
of RNAi-derived wee kinase-deficient embryos, since their122 Developmental Cell 31, 114–127, October 13, 2014 ª2014 Elsevphenotypemirrored that reported for mutantwee embryos (Price
et al., 2000). Wee, Cdk1, and Aurora operate in a regulatory ki-
nase cascade to control nuclear divisions in the early embryo.
Phosphorylation and activation of Aurora by Cdk1 is inhibited
byWee anddelays entry intomitosis.Wee inhibits Cdk1 by phos-
phorylating a conserved tyrosine (Tyr15) located in the ATP bind-
ingpocket (Campbell et al., 1995;Stumpff et al., 2004). Therefore,
we expected Cdk1 and Aurora to be hyperactive in the absence





Figure 7. Identification of Stwl as a Target of
Wee Kinase
(A) Lysates from Drosophila cells expressing
HA-tagged Wee together with 3xFLAG-tagged
candidate Wee substrates were subjected to
immunoprecipitation with anti-FLAG antibody and
analyzed by immunoblotting with the indicated
antibodies.
(B) Lysates from Drosophila cells expressing HA-
tagged Wee together with 3xFLAG-tagged Stwl
were subjected to immunoprecipitation with anti-
phosphotyrosine antibody and analyzed by
immunoblotting with the indicated antibodies.
(C) Recombinant GST-Stwl fusion proteins were
incubated with human WEE1 kinase and radio-
labeled ATP and analyzed by SDS-PAGE and
autoradiography. Histone H2B serves as a positive
control (lane 4). The migration of input proteins is
indicated with asterisks. Autophosphorylated
WEE1 migrates at 120 kDa.
(D) Lysates from 0–2 hr embryos derived from fe-
males expressing shRNAs targeting wee, stwl, or
an EGFP control shRNA were analyzed by immu-
noblotting with anti-Stwl and anti-Wee antibodies.
Immunoblotting with anti-tubulin serves as a
loading control.
(E) Lysates from 0–2 hr embryos derived from fe-
males expressing shRNAs targeting wee, stwl, or
an EGFP control shRNA were analyzed by immu-
noblotting with antibodies recognizing different
histone H3 posttranslational modifications.
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Surveying Phosphorylation Networks in Drosophilaupregulated phosphosites inwee-deficient embryos that resem-
bles Cdk and Aurora kinase consensus motifs (Cdk1: pS/T-P-X-
K/R; pS/T-P-X-X-K and Aurora: R-R/K-pS/T; R/K-X-pS/T; R-R/
K-X-pS/T) (Alexander et al., 2011). Accordingly, we consistently
observed less TMT reporter ion signal proportionate to levels of
Cdk1 Tyr15 phosphopeptides in wee-deficient embryos,
implying Cdk1 hyperactivity in this context (Figure 6B). We
corroborated this observation by immunoblotting with a Cdk1-
pTyr15 antibody (Figure S6A). Significantly, we identified altered
phosphorylation on half of those fly proteins whose orthologous
yeast counterparts were identified as Cdk substrates (Figure 6C)
(Holt et al., 2009). Aurora is also hyperactive inwee-deficient em-
bryos, reflected by the upregulation in phosphorylation of char-
acterized targets: kinesin-like protein at 10A (Klp10A pSer210:
2.5-fold), inner centromere protein (Incenp pSer163: 1.5-fold
and pSer164: 3-fold), and histone H3 (HH3 pSer10: 15-fold;
pSer28: 7-fold) (Adams et al., 2001; Jang et al., 2009; Kang
et al., 2001). We verified HH3 phosphoalterations in wee-defi-
cient embryos by immunoblotting (Figure S6A). Surprisingly,
half of the upregulated phosphosites we identified in wee ki-
nase-deficient embryos reside within sequence recognized by
Cdk1 or downstream Aurora kinase (Figure 6D). This observation
highlights the utility of phosphoproteomic signatures to reveal
genetic epistasis. We also find enrichment for specific Gene
Ontology Consortium categories for those phosphoproteins
regulated by Wee (Figure 6E). As anticipated, we observed
enrichment for cell cycle classified factors, particularly those
withmitosis-specific functions suchas nuclearmigration, spindleDevelopmorganization, and chromosome segregation. Intriguingly, pro-
teins with roles in chromatin assembly are overrepresented in
our list of upregulated phosphoproteins in wee-deficient em-
bryos. This is interesting, given the reported hypocondensation
of mitotic chromatin in wee null embryos (Stumpff et al., 2004).
Motif enrichment among downregulated phosphorylations is
illustrated (Figure S6B). Another indirect consequence of wee
knockdown is the upregulation of Stat92E phosphorylation at
Tyr711 in wee-deficient embryos (Table S5A). Cdk1 has been
shown to regulate Stat92E phosphorylation at Tyr711 in cells
(Baeg et al., 2005), and indeed, we detect elevated Y711-encom-
passingStat92Ephosphopeptides inwee-deficient embryos that
cannot be attributed to increased Stat92E levels (Figure S5B).
Wee functions as a conserved tyrosine kinase (Campbell
et al., 1995; McGowan and Russell, 1993); therefore, we inquired
as to whether any phosphoproteins for which tyrosine phos-
phorylation was reduced in wee-deficient embryos are, in fact,
direct Wee targets. We cloned and tagged eight genes for
expression in D. melanogaster cells, which were selected based
on reduced phosphorylation (>1.5-fold) of the corresponding
protein in wee-deficient embryos. Of these, we observed hem-
agglutinin (HA)-tagged Wee in immunoprecipitates of FLAG-
tagged Stonewall (Stwl: lane 6, Figure 7A). In the reciprocal
direction, we detected FLAG-tagged Klp10A, CG13605, Stwl,
and Polychaetoid (Pyd) in immunoprecipitates of HA-Wee (Fig-
ure S6D). Consistent with our observations, Pyd was previously
identified in Wee-FLAG-HA immune complexes (Guruharsha
et al., 2011).ental Cell 31, 114–127, October 13, 2014 ª2014 Elsevier Inc. 123
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myb/SANT (Swi3, Ada2, N-CoR, TFIIB)-like domain it possesses
has been found to influence histone modifications bymodulating
chromatin structure (Boyer et al., 2004) andweemutant embryos
have reported defects in chromatin condensation (Stumpff et al.,
2004). Like other heterochromatin regulators, Stwl influences
position effect variegation and HH3 methylation in vivo (Maines
et al., 2007; Yi et al., 2009). We found that phosphopeptides en-
compassing Stwl Tyr305 were reduced in wee-deficient em-
bryos (Figure 6F), despite total Stwl levels being elevated (lane
2 versus lane 1: Figure 7D). These alterations in protein cannot
be attributed to mRNA transcript stability (Figure S6C). Based
on our observations that wee is required for Stwl-Tyr305 phos-
phorylation, we examined the effects of wee overexpression
on Tyr phosphorylation of Stwl in cells. Tyr phosphorylation of
Stwl is elevated in cells overexpressing wee, based on phos-
pho-Tyr immunoprecipitation and detection by immunoblotting
(Figure 7B). To ask if Wee can directly phosphorylate Stwl, we
generated His-tagged Stwl-fusion proteins for in vitro kinase as-
says. We incubated purified His-Stwl fragments with human
WEE1 (38% identity, 53% similarity to D. melanogaster Wee).
WEE1 phosphorylated Stwl at multiple sites recognized by a
phospho-Tyr antibody, including fragments encompassing
Tyr305 (Figure 7C, lanes 1 and 2). Interestingly, the BESS
domain-containing fragment consistently inhibited WEE1 kinase
activity, as indicated by reduced WEE1 autophosphorylation,
both as a His-tagged protein (Figure 7C) and as a glutathione
S-transferase (GST)-tagged fusion protein (data not shown).
The BESS motif is likely the region that interacts with Wee, given
that this domain facilitates protein-protein interactions (Bhaskar
and Courey, 2002) and is often found together with the myb/
SANT domain. The BESS motif of Suppressor of variegation
3-7 (Su(var)3-7) is required for its chromatin-silencing properties
(Jaquet et al., 2006). Like Su(var)3-7, Stwl influences trimethyla-
tion of HH3 at Lys9, in addition to Lys27 at larval stages (Yi et al.,
2009). We detected no obvious reduction in these repressive
marks in stwl-depleted embryos. Rather, we observed alter-
ations in trimethylated Lys4 of HH3, an activation mark (Fig-
ure 7E). Consistent with a role for Wee in inhibiting Stwl activity,
HH3 trimethyl Lys4marks are elevated inwee-deficient embryos
(Figure 7E). Effects of wee knockdown on Lys4 methylation in
later stage 2- to 4-hr embryos was confounded by the inability
of wee-deficient embryos to transit the MBT (data not shown).
Based on our observations, we propose that Wee inhibits the
ability of Stwl to modulate histone methylation prior to the
MBT, halting the activation of zygotic transcription to regulate
the timing of transit through the MBT.
DISCUSSION
A Resource to Study Protein Kinases and Phosphatases
in Early Embryos
We generated a validated collection of transgenic
D. melanogaster shRNA lines targeting protein kinases and
phosphatases maternally deposited in embryos. The collection
permits the examination of zygotic lethal gene perturbations,
without the effort of germline clone derivation. Multiple lines of
evidence support that the embryonic phenotypes generated by
our collection are, indeed, a result of shRNA on-targeting: (1)124 Developmental Cell 31, 114–127, October 13, 2014 ª2014 Elsevnear-identical qualitative phenotypes generated by two unique
shRNAs targeting the same gene for the 15% of the collection
we tested; (2) abolition of shRNA-induced phenotypes by substi-
tution of three nucleotides (C911s) precluding on-target binding;
(3) the high degree of overlap between our shRNA-derived phe-
notypes and literature-reported mutant embryo and germline
clone-derived embryo phenotypes; and (4) our general inability
to accredit specific shRNA phenotypes to candidate OTEs
derived from proteomics and partial complementarity matching.
A General Method to Predict Kinase Motifs and Targets
Using our shRNA collection, we performed quantitative phos-
phoproteome assessments of genetically compromised ani-
mals. An advantage of our gene knockdown strategy over
gene knockout is that we restrict RNAi to the germline: since
germline development is dispensable for organismal develop-
ment, our RNAi method likely avoids major adaptation and
compensation due to effects on the viability of the animal, such
as that seen, for example, with yeast deletion mutants (Boden-
miller et al., 2010; Teng et al., 2013). Additionally, the modest
amount of transcription in early-stage embryos further minimizes
the possibility of compensation at the transcriptional level,
although nontranscriptional compensation is a possibility.
Conceivably, by comparing genetic knockout to incomplete
depletion by RNAi-mediated knockdown, one could identify
compensatory rewiring events. From phosphoproteomic
profiling of kinase-deficient embryos, we identified altered phos-
phorylation of characterized substrates of depleted kinases and
generated an extensive list of candidate substrates of the
depleted kinase and altered phosphoproteins targeted by down-
stream kinases. A challenge will be to distinguish between pri-
mary and secondary targets. It is difficult to evaluate the number
of primary targets per kinase since this will depend on multiple
factors, including the function of the kinase and its expression
level, localization, and connectivity with other proteins. Indeed,
studies from yeast and mammalian kinases have illustrated
that the number of substrates for any one kinase can range
from hundreds to only a few (Ubersax and Ferrell, 2007). Thus,
we expect variability in the number of substrates depending on
the analyzed kinase. Furthermore, biologically meaningful alter-
ations in phosphorylationmay have beenmissed in our analyses,
given the limitations of current mass spectrometry technology.
We illustrate, however, that current instrumentation can be
used to identify known and predicted targets relevant to the
function of the perturbed kinase (e.g., Stwl is a direct target of
Wee kinase) and so, despite perhaps only scratching the sur-
face, we have generated biologically pertinent information. Addi-
tional information (e.g., in vitro kinase activity toward a substrate,
protein-protein interaction, and functional assays) is necessary,
of course, to infer a direct KS relationship (Sopko and Andrews,
2008). Undoubtedly, extension of our methodology will be effec-
tive for systematically mapping substrates to culpable kinases
and for pinpointing critical phosphosites important for substrate
function.
Correlation and Anticorrelation: An Application
for Network Analysis
Our correlative analysis examining coordination between alter-
ations in phosphosite pairs among kinase-deficient profilesier Inc.
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for Slik kinase in regulating the transcription factor Stat92E could
be predicted from correlative phosphorylation of these two pro-
teins. The predictive power of this approach could be extended
by knowing if specific phosphorylation events serve activating or
inhibitory functions and by superimposing kinase consensus
motifs. Our analysis demonstrates how functional phosphoryla-
tion might be uncovered in any phosphoproteomic data using
simple correlative principles. Notably, predictions for any partic-
ular kinase can be made indirectly from its detection in varying
genetic contexts, with no requirement for direct modulation of
the queried kinase. The data we generated from embryos will
complement orthogonal data sets such as kinase consensus
motif and protein-protein interaction data derived from, for
example, peptide and protein chip assays, coaffinity purifica-
tions, and yeast two-hybrid assays. Furthermore, phosphosite
correlation information could be integrated with large-scale
RNAi phenotype data in order to predict whether phosphoryla-
tion of a target by a specific kinase serves an activating or inhib-
iting function.
Perspective
Given that key signaling pathways and kinases implicated in hu-
man disease are conserved inDrosophila (Rubin et al., 2000), the
insight gained from our kinase-deficient phosphoproteomic sig-
natures constitutes an important step toward understanding the
kinome network. Going forward, we anticipate that phosphopro-
teomic assessment of other posttranslational modifications and
more complex genotypes, using combinatorial knockdown (two
shRNAs) or knockdown in combination with transgene overex-
pression or gain-of-function mutations, will appreciably illumi-
nate our ability to decipher signaling mechanisms. In this way,
global proteomic analyses could map pathways but also reveal
critical nodes in signaling that may partially or completely over-
comemutations resulting in pathway hyperactivity. Alternatively,
phosphoproteomic assessment of a sensitized kinase mutant in
the context of a substrate gain of function could expose altered
signaling mechanisms contributing to compromised viability
(Sopko et al., 2006). Finally, genetic combinations would mimic
more natural scenarios in terms of genetic heterogeneity contrib-
uting to susceptibility to disease and, by mapping contextual
phosphorylation, would improve on our ability to predict and
target essential signaling nodes.
EXPERIMENTAL PROCEDURES
Detailed methods are available in the Supplemental Experimental Procedures.
Mass spectrometric sample preparation is further described in the Protocol.
Transgenic shRNA Line Generation
shRNAs (21 base pairs) were cloned into VALIUM series vectors and injected
into embryos for targeted phiC31-mediated integration at genomic attP land-
ing sites on the second or third chromosome as described elsewhere (Ni et al.,
2011). All transgenic lines were sequenced to confirm the identity of the shRNA
and miR-1 scaffold.
Protein Kinase or Phosphatase-Deficient Embryo Derivation
Females heterozygous for the UAS-shRNA and either MTD-Gal4 (Petrella
et al., 2007), expressing three versions of Gal4 sequentially throughout
oogenesis, or tub-Gal4, a line expressing Gal4 from a maternal tubulin
promoter at two insertion sites during mid- and late oogenesis (StallerDevelopmet al., 2013), were crossed to UAS-shRNA males to recover fertilized
embryos.
RNA Isolation, Reverse Transcription, and Real-Time qPCR
RNA was isolated by guanidinium thiocyanate-phenol-chloroform extraction
using TRIzol (Life Technologies) and glass-bead-based cell disruption.
Genomic DNA was eliminated by incubation with DNase (QIAGEN), and sam-
ples were processed for cleanup with an RNeasy MinElute Cleanup Kit
(QIAGEN).
One microgram of purified RNA was incubated with a mix of oligo(dT) and
random hexamer primers and with iScript RT (iScript cDNA Synthesis Kit,
Bio-Rad) for complementary DNA (cDNA) synthesis. cDNA was used as the
template for amplification, using validated primers in iQ SYBRGreen Supermix
with a CFX96 Real-Time PCR detection system (Bio-Rad). Query gene expres-
sion was relative to a control sample, normalized to the expression of three
reference genes: ribosomal protein L32, alpha-tubulin, and either nuclear
fallout or Gapdh1, using the DDC(t) analysis method.
Maternal Phenotype Derivation
Hatch rate was calculated from counting embryos 24 hr after deposition. For
genotypes with defective hatching, cuticles prepared in Hoyer’s mountingme-
dia were imaged with a Zeiss AxioCam HRC Camera mounted on a Zeiss
Axiophot microscope.
Coimmunoprecipitation and Immunoblotting
Lysates were subjected to immunoprecipitation using the indicated anti-
bodies, and samples were subjected to SDS-PAGE followed by
immunoblotting.
Quantitative Phosphoproteomics
Embryos lysed in 8 M urea were digested with trypsin, and peptides were
chemically labeled with one of six TMT Isobaric Mass Tags (Thermo Fisher
Scientific), separated into 12 fractions by strong cation exchange chromatog-
raphy, purified with TiO2 microspheres, and analyzed via liquid chromatog-
raphy-tandem mass spectrometry on an Orbitrap Velos Pro mass spectrom-
eter (Thermo Fisher Scientific). Peptides were identified by Sequest and
filtered to a 1% peptide false discovery rate (FDR). Proteins were filtered to
achieve a 2% final protein FDR (final peptide FDR near 0.15%). TMT reporter
ion intensities for individual phosphopeptides were normalized to the summed
reporter ion intensity for each TMT label. The localizations of phosphorylations
were assigned using the AScore algorithm.
In Vitro Kinase Assay
In vitro kinase assays were carried out as described elsewhere (Sopko et al.,
2006).
Correlative Analysis
A phosphosite matrix was constructed where rows correspond to identified
phosphosites and columns correspond to kinase-deficient data sets. Only
phosphosites with R0.58 log2-fold change were distinguished, by values +1
and 1, based on an increase or decrease, respectively, in levels relative to
an shRNA control. All pairwise combinations of phosphosites were classified
as positive or negative correlating based on their change in the same or oppo-
site direction, respectively, for each kinase-deficient condition. A correlation
sign score was determined, considering the number of positive and negative
correlations and the total number of kinase-deficient phosphorylation profiles
where both phosphosites change.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, seven tables, and a Protocol and can be found with this article on-
line at http://dx.doi.org/10.1016/j.devcel.2014.07.027.
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